Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Haemonetics Corp (NYSE:HAE)

35.95
Delayed Data
As of Aug 28
 -0.17 / -0.47%
Today’s Change
33.75
Today|||52-Week Range
45.43
-3.93%
Year-to-Date
No recent news for Haemonetics Corp.

Today’s Trading

Previous close36.12
Today’s open36.08
Day’s range35.73 - 36.24
Volume578,305
Average volume (3 months)306,709
Market cap$1.8B
Dividend yield--
Data as of 4:05pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)-52.24%
Earnings growth (this year)+9.24%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)-3.00%
P/E ratio92.2
Price/Sales2.53
Price/Book2.25

Competitors

 Today’s
change
Today’s
% change
ICUIICU Medical Inc+0.47+0.41%
PODDInsulet Corp+0.36+1.23%
MASIMasimo Corp-0.63-1.50%
EXASExact Sciences Corp+0.15+0.68%
Data as of 3:59pm ET, 08/28/2015

Financials

Next reporting dateNovember 2, 2015
EPS forecast (this quarter)$0.39
Annual revenue (last year)$910.4M
Annual profit (last year)$16.9M
Net profit margin1.86%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Brian P. Concannon
Chief Operating Officer
Kent J. Davies
Corporate headquarters
Braintree, Massachusetts

Forecasts

Partner Offers